Horne, K. C., Howden, B. P., Grabsch, E. A., Graham, M., Ward, P. B., Xie, S., . . . Grayson, M. L. (2009). Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA. American Society for Microbiology (ASM).
Citação norma ChicagoHorne, K. C., B. P. Howden, E. A. Grabsch, M. Graham, P. B. Ward, S. Xie, B. C. Mayall, P. D. R. Johnson, and M. L. Grayson. Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus Aureus (MRSA) and Vancomycin-Susceptible MRSA. American Society for Microbiology (ASM), 2009.
MLA CitationHorne, K. C., et al. Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus Aureus (MRSA) and Vancomycin-Susceptible MRSA. American Society for Microbiology (ASM), 2009.